¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ

For International Women’s Day (8 March), the ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Festival (19 March – 4 April) is celebrating some of the remarkable contributions of women across diverse fields. From philosophy and music to AI and cosmology, the festival will highlight the pioneering work of women who have shaped our understanding of the world in profound ways.

A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.

Today sees the launch of the Early Cancer Institute at ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ. Its mission is deceptively simple: to detect cancer early enough to cure it.

Find out about groundbreaking cancer research at ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ, including our planned new hospital, how we're studying the earliest stages of cancer, how AI is helping fight the disease, and the patients playing a key role in our work.

Two-thirds of the public say they are very or somewhat worried about being told they have cancer – higher than for any other medical condition – according to polling released today.

Work will begin soon on a new hospital that will transform how we diagnose and treat cancer. ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ Cancer Research Hospital will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond.

Ten outstanding ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ researchers have been elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.

The ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ’s Early Cancer Institute – the UK's only research facility dedicated to understanding early cancer – has received a landmark £11 million donation to support its vital work in the fight against cancer.

A new test to help diagnose a condition that can lead to oesophageal cancer – developed by ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ researchers and trialled by the NHS – has reduced the need for invasive endoscopy in thousands of low-risk patients.

A man from ¹ú¼ÊÃ×À¼¶ÔÕó¿ÆĪ is the first to join the surveillance part of a clinical trial that could see routine screening for oesophageal cancer introduced into the NHS, potentially halving deaths from this cancer every year.